These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 20102553

  • 21. Rescue immunosuppression with mammalian target of rapamycin inhibitor drugs in liver transplantation.
    Mártinez JM, Pulido LB, Bellido CB, Usero DD, Aguilar LT, Moreno JL, Artacho GS, Díez-Canedo JS, Gómez LM, Bravo MA.
    Transplant Proc; 2010 Mar; 42(2):641-3. PubMed ID: 20304212
    [Abstract] [Full Text] [Related]

  • 22. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D, Di Salvo T, Mathier M, Keck S, Semigran M, Dec GW.
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [Abstract] [Full Text] [Related]

  • 23. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
    Bayliss J, Bailey M, Leet A, Stein AN, Thomson NM, McLean CA.
    Transplantation; 2008 Oct 15; 86(7):991-7. PubMed ID: 18852667
    [Abstract] [Full Text] [Related]

  • 24. Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement.
    Lang UE, Heger J, Willbring M, Domula M, Matschke K, Tugtekin SM.
    Transplant Proc; 2009 Dec 15; 41(10):4285-8. PubMed ID: 20005385
    [Abstract] [Full Text] [Related]

  • 25. Reduced circulating angiogenic cells in Alzheimer disease.
    Lee ST, Chu K, Jung KH, Park HK, Kim DH, Bahn JJ, Kim JH, Oh MJ, Lee SK, Kim M, Roh JK.
    Neurology; 2009 May 26; 72(21):1858-63. PubMed ID: 19470969
    [Abstract] [Full Text] [Related]

  • 26. Circulating CD34+/KDR+ endothelial progenitor cells are reduced in chronic heart failure patients as a function of Type D personality.
    Van Craenenbroeck EM, Denollet J, Paelinck BP, Beckers P, Possemiers N, Hoymans VY, Vrints CJ, Conraads VM.
    Clin Sci (Lond); 2009 Jul 16; 117(4):165-72. PubMed ID: 19173675
    [Abstract] [Full Text] [Related]

  • 27. Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis.
    Viganò M, Tuzcu M, Benza R, Boissonnat P, Haverich A, Hill J, Laufer G, Love R, Parameshwar J, Pulpón LA, Renlund D, Abeywickrama K, Cretin N, Starling RC, Eisen HJ, RAD B253 Study Group.
    J Heart Lung Transplant; 2007 Jun 16; 26(6):584-92. PubMed ID: 17543781
    [Abstract] [Full Text] [Related]

  • 28. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure.
    Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK.
    Arterioscler Thromb Vasc Biol; 2004 Jul 16; 24(7):1246-52. PubMed ID: 15155385
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Detection of cardiac allograft rejection by real-time PCR analysis of circulating mononuclear cells.
    Schoels M, Dengler TJ, Richter R, Meuer SC, Giese T.
    Clin Transplant; 2004 Oct 16; 18(5):513-7. PubMed ID: 15344952
    [Abstract] [Full Text] [Related]

  • 35. Endothelial progenitor cells are mobilized after cardiac surgery.
    Roberts N, Xiao Q, Weir G, Xu Q, Jahangiri M.
    Ann Thorac Surg; 2007 Feb 16; 83(2):598-605. PubMed ID: 17257994
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity.
    Avouac J, Juin F, Wipff J, Couraud PO, Chiocchia G, Kahan A, Boileau C, Uzan G, Allanore Y.
    Ann Rheum Dis; 2008 Oct 16; 67(10):1455-60. PubMed ID: 18174219
    [Abstract] [Full Text] [Related]

  • 39. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S, Wang XM, Chia D, Ozawa M, Zhong HP, Hirata M, Terasaki PI, Kobashigawa JA.
    J Heart Lung Transplant; 1998 Apr 16; 17(4):335-40. PubMed ID: 9588577
    [Abstract] [Full Text] [Related]

  • 40. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
    Honold J, Lehmann R, Heeschen C, Walter DH, Assmus B, Sasaki K, Martin H, Haendeler J, Zeiher AM, Dimmeler S.
    Arterioscler Thromb Vasc Biol; 2006 Oct 16; 26(10):2238-43. PubMed ID: 16902165
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.